Phase 3 Type 1 Diabetes Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have a clinical history of Type 1 Diabetes (a condition where the body cannot produce insulin) and have needed insulin for at least 5 years
• People who have been on a stable anti-rejection medication routine — specifically tacrolimus combined with either mycophenolate mofetil, mycophenolate sodium, or sirolimus — for at least 4 weeks
• People who have been consistently using a Continuous Glucose Monitor (a small device that tracks blood sugar levels automatically) for at least 4 weeks before the screening visit, and who are willing to keep using one throughout the study

Who may not be able to join:

• People who have previously received an islet cell transplant (a procedure involving transplanting insulin-producing cells), an organ transplant other than a kidney transplant, or any cell therapy — unless a previous pancreatic graft stopped working within the first 4 weeks
• People who have had more than one kidney transplant procedure

Additional eligibility criteria set out in the study protocol may also apply — the trial site will be able to provide full details.

Important: Always verify eligibility with the trial site directly before applying.